Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation

NCT01719367 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Atenolol

Sponsor

Vanderbilt University Medical Center